Geen categorie

11 januari 2021

Health~Holland public-private-partnership grant award of 0.9 M€

ROTTERDAM, The Netherlands, January 11, 2021 – The partnership between the young company Pan Cancer T B.V. and Erasmus MC is awarded a Health~Holland grant of […]
18 januari 2023

Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer

– Strengthening of T cell research expertise to develop next-generation T cell therapies for patients with limited or no treatment options  ROTTERDAM, January 17, 2023 – […]
23 februari 2023

Pan Cancer T Appoints Prof. Dr. Chiara Bonini to its Scientific Advisory Board

– Leading European T cell therapy researcher adds further scientific expertise   ROTTERDAM, February 23, 2023 – Pan Cancer T B.V., a biotech spin-off from Erasmus […]
12 mei 2023

Pan Cancer T appoints Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer

ROTTERDAM, May 11, 2023 – Pan Cancer T B.V., a biotech spin-off from Erasmus MC dedicated to the discovery and development of next-generation TCR-T therapies against […]
30 maart 2021

Pan Cancer T B.V. Appoints Seasoned Entrepreneurs and Executives to its Supervisory Board and Elects its Chairman

– John Tchelingerian, PhD (Chair), Dharminder Singh Chahal and Prof. Dr. Chris Bangma to form Supervisory Board ROTTERDAM, March 30, 2021 – Pan Cancer T B.V., […]
27 september 2021

Pan Cancer T celebrates 1-year anniversary!

Pan Cancer T B-day_2021 (2)
28 oktober 2021

Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital

Expanded investor syndicate strengthens the company’s financial position and investor base   ROTTERDAM, October 28, 2021 – Pan Cancer T B.V., a biotech spin-off from the […]
27 februari 2024

Pan Cancer T has been awarded the Seal of Excellence from the European Commission

Amongst a record number of applicants, Pan Cancer T’s EIC Accelerator proposal has been awarded the Seal of Excellence. The EIC Accelerator Seal of Excellence and […]
1 november 2023

Pan Cancer T has been selected as semi finalist of the EIT Health Catapult venture challenge

Pan Cancer T’s CEO Rachel Abbott, will participate in the semi finals of the EIT Health Catapult! For more information about the venture challenge see